🇨🇦 Lymphostat B in Canada

Lymphostat B (BELIMUMAB) regulatory status in Canada.

Marketing authorisation

Lymphostat B in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Canada

Frequently asked questions

Is Lymphostat B approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Lymphostat B in Canada?

Human Genome Sciences Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.